Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: fetal + toxicity + 0.33  Related to the article below (Last Update: 8/5/2008)

Gilead Sciences And Merck & Co., Inc. Agree To Register And ...
Medical News Today (press release), UK -
Atripla may cause fetal harm when administered during the first trimester to a pregnant woman. Women should not become pregnant or breast-feed while taking ...MRK - GILD
Growth Inhibition of Human Colon Cancer Cells By Plant Compounds
RedOrbit, TX - Aug 1, 2008
Cells were cultured (370C, 5% CO2) in Dulbecco's modified Eagle s medium supplemented with 10% fetal bovine serum, penicillin/ streptomycin, glutamine, ...
EPA-holes
Grist Magazine, WA - Jul 31, 2008
And that's not all: This exposure has been allowed despite the fact that the chemical ends up in mothers' breast milk and poses potential toxicity to fetal ...
Published Study Confirms Safety of InterHealth?s Super CitriMax?
NPIcenter (press release), Canada - Jul 10, 2008
There was no evidence of maternal or fetal toxicity in their offspring as well. ?This study is the latest in a massive body of research that confirms the ...
Pesticides Found In Soap, Toothpaste And Toys
WPXI.com, PA - Jul 17, 2008
According to the Environmental Working Group the chemical can end up in mothers' breast milk and poses potential toxicity to fetal and childhood development ...
Women Exposed To High Levels of Pollutant PCB More Likely To Give ...
Science Daily (press release) - Jul 15, 2008
PCBs were banned in the 1970s because of their general toxicity and persistence. They are associated with effects on immune, reproductive, nervous, ...

Hindu Business Line
?We plan to bring out innovative tailor-made cells for diseases?
Hindu Business Line, India - Jul 27, 2008
Broadly there are three types of stem cells depending from the source of origin: Human Embryonic Stem Cells (HESCs), Fetal Stem Cells and Adult Stem Cells. ...
Hypertensive Disorders of Pregnancy
RedOrbit, TX - Jul 15, 2008
Fetal growth may be assessed by serial fundal height measurements supplemented by ultrasonography every four weeks starting at 28 weeks of gestation.4 ...
Frankly Speaking by Frank Jordan - July 12
Liberty Vindicator, TX - Jul 12, 2008
The FDA has approved the product for mass consumption in spite of overwhelming evidence that aspartame can have neurotoxic, metabolic, fetal and ...

Philadelphia Center City Weekly Press
OPED: Our stolen evidence?against the Pesticide/Dioxin Cartel
Philadelphia Center City Weekly Press, PA - Jul 9, 2008
But, it is famous, especially from the Viet Nam horrors of Agent Orange, that dioxin, by-product of industrial chlorine, causes fetal damage and baby ...
Source: Google News

Embryonic-fetal toxicity and teratogenic effects of adipic acid esters in rats -
AR Singh, WH Lawrence, J Autian - J. Pharm. Sci, 1973 - doi.wiley.com
... 3.91 f 0.02 4.40 f 0.33 4.10 f 0. I3 3.89 f 0.09 3.94 f ... plasticizers, it was decided
to initiate embryonic-fetal toxicity and teratogenic tests in rats with ...

Polychlorinated Biphenyls (PCBs): Environmental Impact, Biochemical and Toxic Responses, and … -
SH Safe - Critical Reviews in Toxicology, 1994 - informaworld.com
... 1.5 1.4 0.33 0.85 0.1 1 ... adverse impacts of the indi- vidual congeners and their
concentrations in these samples and should not rely solely on the toxicity of a ...

Fetal toxicity and distribution of paraquat and diquat in mice and rats -
JS Bus, MM Preache, SZ Cagen, HS Posner, BC … - Toxicology and Applied Pharmacology, 1975 - Elsevier
... 0.38 0.18 1.65 1.30 0.63 0.16 21 0.81 0.82 0.65 0.33 2.82 1.16 ... a high degree of maternal
mortality and thus cannot necessarily be attributed to fetal toxicity. ...

Fetal toxicity of cadmium chloride: the pharmacokinetics in the pregnant Wistar rat -
AA Levin, RW Kilpper, RK Miller - Teratology, 1987 - doi.wiley.com
... Kidney 0.86 6.67 0.33 0.14 ... after 12 hours in this study and in previous studies
(Levin et al., '81) supports the as- sumption of a fetal toxicity of cadmium at ...

The developmental toxicity of ethylene glycol in rats and mice -
CJ Price, CA Kimmel, RW Tyl, MC Marr - Toxicology and Applied Pharmacology, 1985 - Elsevier
... 1250 2500 5000 28 28 29 27 NS 14.21 0.26 13.64 0.33 12.72 0.62 ... Wallach, 1974; Marshall
and Cheng, 1983) in mediating maternal and fetal toxicity also deserves ...

Maternal passive smoking during pregnancy and fetal developmental toxicity. Part 1: gross … -
E Nelson, K Jodscheit, Y Guo - Human & Experimental Toxicology, 1999 - het.sagepub.com
... ukl/et Maternal passive smoking during pregnancy and fetal developmental
toxicity. Part 1: gross morphological effects Ed Nelson ...

… Biotransformation Enzymes in Human Fetal Olfactory Mucosa: Potential Roles in Developmental Toxicity -
J Gu, T Su, Y Chen, QY Zhang, X Ding - Toxicology and Applied Pharmacology, 2000 - Elsevier
... man OM and suggest that the human fetal OM may ... a preferred target tissue for the
toxicity of maternally ... expressed CYP2A6 in Sf9 cell microsomes (0.33 nmol P450 ...

The Developmental Toxicity of Diethylene Glycol Dimethyl Ether in Mice 1 -
CJ PRICE, CA KIMMEL, JD GEORGE, MC MARR - Toxicological Sciences, 1987 - Soc Toxicology
... 31.03 ?0.33 53.41 ? 1.35 22.38 ? 1.36 13.30 ?0.84 6.00 ?0.54 16.38 ... DEVELOPMENTAL
TOXICITY OF diEGdiME 121 ... effects including an in- crease in fetal death at ...

Validation of an in vivo developmental toxicity screen in the mouse -
JM Seidenberg, DG Anderson, RA Becker - Teratogen. Carcinogen. Mutagen, 1986 - doi.wiley.com
... teratogenicity testing. Key words: teratology , fetal toxicity, embryotoxicity,
neonatal toxicity, teratology screen INTRODUCTION In ...

Comparison of maternal and fetal toxic dose responses in mammals -
JM Rogers - Teratog. Carcinog. Mutagen, 1987 - doi.wiley.com
... One compound, deltamethrin, produced no fetal toxicity among litters of surviving
dams, demonstrating that maternal toxicity can occur without concomitant ...

Source: Google Scholar
 

Janice and Rodney Dietert

Provided

Janice and Rodney Dietert display herbal and fungal medicinal sources that show promise for addressing developmental immunotoxicity (DIT) and DIT-associated diseases. On the tray are: sang-hwang mushroom, Panax ginseng, echinacea, shiitake mushroom and astragalus.

Researchers find that later-life diseases resulting from fetal and infant toxicity have common immune pattern

By Susan Lang

A Cornell researcher and his wife have conducted the first comprehensive review of later-life diseases that develop in people who were exposed to environmental toxins or drugs either in the womb or as infants. They have found that most of the diseases have two things in common: They involve an imbalanced immune system and exaggerated inflammatory reactions (at the cellular level).

In an invited, peer-reviewed article on developmental immunotoxicity (DIT), published in a recent issue of Current Medicinal Chemistry, Rodney Dietert, professor of immunotoxicology at Cornell's College of Veterinary Medicine, and Janice Dietert of Performance Plus Consulting in Lansing, N.Y., found that almost all the chronic diseases that are associated with DIT share the same type of immunological damage.

Article continues below and (thank you)

 

 

The diseases linked to DIT include asthma, allergy, suppressed responses to vaccines, increased susceptibility to infections, childhood neurobehavioral conditions, autoimmunity, cancer, cerebral palsy, atherosclerosis, hypertension and male sterility.

Toxins that are known to cause developmental immune problems in fetuses and neonates, according to the Dieterts, include herbicides, pesticides, alcohol, heavy metals, maternal smoking, antibiotics, diesel exhaust, drugs of abuse and PCBs.

Antidotes to DIT, the researchers note, could come from a variety of sources, including herbal and fungal chemicals -- from mushrooms to clover -- which appear to have promise.

Two immune processes -- T helper (Th) cell balances and dendritic cell maturation -- are both compromised in ways that disrupt the regulation of inflammatory cell function, which leads to exaggerated inflammatory responses.

"Most therapeutic approaches have looked at specific disease outcomes from DIT, rather than focusing on the underlying immune dysfunction that creates the increased disease risk," said Rodney Dietert, who also presented his findings March 28 at the annual Society of Toxicology meeting in Charlotte, N.C. "Instead, we looked at the common immune dysfunction that is related to a host of diseases."

Knowing the most common immune dysfunction patterns from DIT allows researchers to consider more seriously those "medicinals with the capacity to restore inflammatory cell regulation, promote dendritic cell maturation and restore desirable Th balance that would be the most likely candidates to combat the problems resulting from DIT."

Focusing on studies of herbal and fungal chemicals, the Dieterts scoured the literature and found that some of the chemicals appear to be particularly promising when taken at appropriate doses. These include: Astragalus; Echinacea (purple coneflower); sang-hwang shiitake, reishi, maitake and snake butter mushrooms, black seed, Asian ginseng, milk vetch root, wild yam, Sophoro root and Greek clover (all of these also go by various other names).

In their paper, the Dieterts also list a multitude of substances that have been found to have "an uncertain impact" on DIT as well as several found to exacerbate immune dysfunction (including marijuana).

"We hope that these findings of persistent immune dysfunction from gestational exposure will provide encouragement for additional research. Furthermore, that researchers will look at these categories of medicines that have the possibility of correcting inflammatory and immune balance problems resulting from DIT rather than focusing solely on individual disease symptoms," Rodney Dietert said.

He noted that until recently toxin-testing guidelines predicted only risk in adults, but that the Environmental Protection Agency has announced it will issue new guidelines to take into account the increased immune sensitivity of fetuses and young children.

 

 

Work with Nanoparticles May Lead to 'On-the-Spot' Virus Detector

BUFFALO, N.Y. -- Chemical engineers from the University at Buffalo have collaborated with scientists from other institutions to solve a critical bottleneck in the transport and capture of virus nanoparticles, making possible a device that could rapidly sample and detect infectious biological agents, such as viruses.

"This advance may pave the way for an 'on-the-spot' virus detector, which would be immensely helpful, especially in military and public-health applications," said Paschalis Alexandridis, Ph.D., professor in the Department of Chemical and Biological Engineering in the UB School of Engineering and Applied Sciences and co-author on the research.

A paper describing the results was published in the March issue of Langmuir (vol. 23, p. 3840).

The rapid detection of viruses in biological samples is of increasing interest, particularly with the recent emergence of new viruses, including SARS, West Nile virus and avian flu virus.

But because viral particles are present at such low concentrations in biological samples, such as blood, a device that can quickly and easily detect them has remained elusive.

Typical procedures involve using passive diffusion to get the viral particles to bind to an antibody, a slow process that is not feasible for many applications, such as on the battlefield, where quick results are critical.

Scientists at the University of Wisconsin at Madison led by Nicholas L. Abbott, Ph.D., a co-author on the paper and John T. and Magdalen L. Sobota Professor of Chemical and Biological Engineering, previously had demonstrated that liquid crystals can amplify signals from low concentrations of viral particles, quickly indicating whether or not a virus is present on a surface.

"The bottleneck was how to transport and capture enough suspected viral particles onto a surface in a timely fashion so that they could be detected," said Alexandridis. "During the acute phase of an infection, the virus is at a very low concentration and relying on passive diffusion to deposit the viral particles onto the detection surface can be time-consuming."

The researchers wanted to speed up the collection of viral particles -- in this case, of vesicular stomatitis virus, a common animal virus -- at the right place on a substrate, while also doing it in media at physiological ionic strength.

The UB researchers used their expertise in a technique called directed assembly, in which they design external electrical and fluid flow fields in order to "drive" nanoparticles to specific locations and in specific concentrations on a substrate.

"This paper shows that by using electrodes separated by just a few micrometers together with electrothermally induced fluid flow, we can accelerate the transport of viral particles from aqueous suspensions with physiological ionic strength to specific points on a surface, allowing them to reach local concentrations high enough to allow subsequent rapid detection," Alexandridis explained.

"We achieved this not by accident, but by design," he continued. "We hypothesized that the application of these external fields would cause the nanoparticles to act in a certain way. We designed electrodes to generate the required forces for the system of interest and then put our design to the test."

In the research, the UB engineers used directed assembly to tailor dielectrophoretic forces, which act through a nonuniform electric field, overcoming an obstacle that occurs whenever nanoparticles are involved.

"When you work with microscopic objects dispersed in a liquid, gravity is very important," explained Alexandridis. "But at the nanoscale, gravity doesn't matter. So when you are trying to manipulate matter at the nanoscale, electrical fields and fluid fields may work best. By using directed assembly, we can tailor the forces acting on the nanoparticles. The ability to use several forces acting in tandem becomes important."

Electrical fields in particular, he said, are advantageous because by designing the electrodes in a certain way, engineers can control directionality and intensity of electrical forces acting on nanoparticles.

Alexandridis conducted the research with Aristides Docoslis, Ph.D., formerly a doctoral candidate and postdoctoral associate in Alexandridis' lab at UB and now the Canada Research Chair of Colloids and Surface Engineering at Queen's University at Kingston.

Additional co-authors are Luis A. Tercero Espinoza, Ph.D., of the Department of Chemical and Biological Engineering, University of Wisconsin at Madison; Bingbing Zhang, Ph.D., of Queen's University at Kingston, and Li-Lin Cheng, Ph.D., and Barbara A. Israel, Ph.D., of the Veterinary School of the University of Wisconsin at Madison.

The research was funded by a National Science Foundation grant in Nanoscale Exploratory Research and by the Gerald A. Sterbutzal Research Fund, administered by the UB School of Engineering and Applied Sciences.

The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York.

 
Google
Web www.iconocast.com
 
 
Continue News With: News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast